Naoshi Obara

4.6k total citations
84 papers, 1.4k citations indexed

About

Naoshi Obara is a scholar working on Hematology, Immunology and Molecular Biology. According to data from OpenAlex, Naoshi Obara has authored 84 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Hematology, 24 papers in Immunology and 18 papers in Molecular Biology. Recurrent topics in Naoshi Obara's work include Hematopoietic Stem Cell Transplantation (19 papers), Complement system in diseases (16 papers) and Platelet Disorders and Treatments (10 papers). Naoshi Obara is often cited by papers focused on Hematopoietic Stem Cell Transplantation (19 papers), Complement system in diseases (16 papers) and Platelet Disorders and Treatments (10 papers). Naoshi Obara collaborates with scholars based in Japan, United States and Spain. Naoshi Obara's co-authors include Masayuki Yamamoto, Norio Suzuki, Shigehiko Imagawa, Toshiro Nagasawa, Shigeru Chiba, Yuko Suzuki, Mamiko Sakata‐Yanagimoto, Xiaoqing Pan, Yuichi Hasegawa and Satoru Takahashi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Molecular and Cellular Biology.

In The Last Decade

Naoshi Obara

77 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Naoshi Obara Japan 20 544 538 283 276 247 84 1.4k
Joachim R. Göthert Germany 25 490 0.9× 1.3k 2.4× 322 1.1× 244 0.9× 150 0.6× 55 2.2k
Dianne Mitchell United States 17 256 0.5× 814 1.5× 252 0.9× 178 0.6× 162 0.7× 28 1.4k
Nathalie Kertesz United States 10 309 0.6× 1.1k 2.1× 216 0.8× 178 0.6× 128 0.5× 14 1.7k
Maher Hanoun Germany 12 671 1.2× 414 0.8× 474 1.7× 109 0.4× 104 0.4× 24 1.5k
Frances Donovan United States 8 339 0.6× 442 0.8× 154 0.5× 351 1.3× 113 0.5× 11 1.5k
Sally K. Martin Australia 18 393 0.7× 553 1.0× 158 0.6× 158 0.6× 78 0.3× 27 1.2k
Weston P. Miller United States 25 373 0.7× 814 1.5× 223 0.8× 87 0.3× 484 2.0× 72 1.7k
Laurel S. Kleppe United States 20 221 0.4× 472 0.9× 155 0.5× 171 0.6× 90 0.4× 32 1.4k
Drorit Luria Israel 19 266 0.5× 393 0.7× 99 0.3× 142 0.5× 140 0.6× 40 939
Kyung Chin United States 17 762 1.4× 480 0.9× 408 1.4× 126 0.5× 266 1.1× 28 1.3k

Countries citing papers authored by Naoshi Obara

Since Specialization
Citations

This map shows the geographic impact of Naoshi Obara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naoshi Obara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naoshi Obara more than expected).

Fields of papers citing papers by Naoshi Obara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naoshi Obara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naoshi Obara. The network helps show where Naoshi Obara may publish in the future.

Co-authorship network of co-authors of Naoshi Obara

This figure shows the co-authorship network connecting the top 25 collaborators of Naoshi Obara. A scholar is included among the top collaborators of Naoshi Obara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naoshi Obara. Naoshi Obara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sakamoto, Tatsuhiro, Hirayasu Kai, Toshiaki Usui, et al.. (2025). Multiple Myeloma in a Patient with Birt-Hogg-Dubé Syndrome. Internal Medicine. 64(18). 2764–2768. 1 indexed citations
2.
Obara, Naoshi, et al.. (2024). Burden of illness in Japanese patients with paroxysmal nocturnal hemoglobinuria receiving C5 inhibitors. International Journal of Hematology. 119(3). 255–264. 1 indexed citations
4.
Obara, Naoshi, et al.. (2024). Long-term safety and effectiveness of romiplostim for chronic idiopathic thrombocytopenic purpura in real-world settings. International Journal of Hematology. 120(6). 665–674. 1 indexed citations
6.
Ishiyama, Ken, Yuji Yonemura, Tatsuya Kawaguchi, et al.. (2023). A longitudinal analysis of paroxysmal nocturnal haemoglobinuria‐type cells in patients with bone marrow failure: Results of a prospective multi‐centre study in Japan. British Journal of Haematology. 203(3). 468–476. 1 indexed citations
7.
Sakamoto, Tatsuhiro, Naoshi Obara, Yumiko Maruyama, et al.. (2023). Repeated immunosuppressive rabbit antithymocyte globulin therapy for adult patients with relapsed or refractory aplastic anemia. European Journal Of Haematology. 111(5). 768–776. 1 indexed citations
8.
Usuki, Kensuke, Takayuki Ikezoe, Ken Ishiyama, et al.. (2023). Interim analysis of post-marketing surveillance of ravulizumab for paroxysmal nocturnal hemoglobinuria in Japan. International Journal of Hematology. 118(3). 311–322. 3 indexed citations
9.
Röth, Alexander, Satoshi Ichikawa, Yoshikazu Ito, et al.. (2023). Crovalimab treatment in patients with paroxysmal nocturnal haemoglobinuria: Long‐term results from the phase I/II COMPOSER trial. European Journal Of Haematology. 111(2). 300–310. 10 indexed citations
10.
Ikezoe, Takayuki, Hideyoshi Noji, Yasutaka Ueda, et al.. (2022). Long-term follow-up of patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab: post-marketing surveillance in Japan. International Journal of Hematology. 115(4). 470–480. 8 indexed citations
11.
12.
Obara, Naoshi, Tatsuhiro Sakamoto, Takayasu Kato, et al.. (2019). Prominence of nestin-expressing Schwann cells in bone marrow of patients with myelodysplastic syndromes with severe fibrosis. International Journal of Hematology. 109(3). 309–318. 6 indexed citations
13.
Obara, Naoshi, Tatsuhiro Sakamoto, Manabu Kusakabe, et al.. (2018). An Unprecedented Case of p190 BCR-ABL Chronic Myeloid Leukemia Diagnosed during Treatment for Multiple Myeloma: A Case Report and Review of the Literature. SHILAP Revista de lepidopterología. 2018. 1–5. 5 indexed citations
14.
Suehara, Yasuhito, Mamiko Sakata‐Yanagimoto, Keiichiro Hattori, et al.. (2017). Liquid Biopsy for the Identification of Intravascular Large B-Cell Lymphoma. Blood. 130. 378–378. 6 indexed citations
15.
Ninomiya, Haruhiko, Naoshi Obara, Yasuhisa Yokoyama, et al.. (2015). Improvement of Renal Function by Long-Term Sustained Eculizumab Treatment in a Patient with Paroxysmal Nocturnal Hemoglobinuria. SHILAP Revista de lepidopterología. 2015. 1–4. 1 indexed citations
16.
Kurita, Naoki, Naoshi Obara, Hidekazu Nishikii, et al.. (2013). Perisurgical induction of eculizumab in a patient with paroxysmal nocturnal hemoglobinuria. Blood Coagulation & Fibrinolysis. 24(6). 658–662. 3 indexed citations
17.
SEKI, Masanori, Naoki Kurita, Yasuhisa Yokoyama, et al.. (2013). Peripherally Inserted Central Catheters Are a Good Option For Venous Access In The Patients With Hematologic Diseases. Blood. 122(21). 2956–2956. 4 indexed citations
18.
Suzuki, Norio, Naoshi Obara, Xiaoqing Pan, et al.. (2011). Specific Contribution of the Erythropoietin Gene 3′ Enhancer to Hepatic Erythropoiesis after Late Embryonic Stages. Molecular and Cellular Biology. 31(18). 3896–3905. 54 indexed citations
19.
Imagawa, Shigehiko, Norio Suzuki, Ken Ohmine, et al.. (2002). GATA Suppresses Erythropoietin Gene Expression through GATA Site in Mouse Erythropoietin Gene Promoter. International Journal of Hematology. 75(4). 376–381. 21 indexed citations
20.
Obara, Naoshi, Yuko Suzuki, Yasuko Nagai, & Masako Takeda. (1998). Expression of E- and P-cadherin during tooth morphogenesis and cytodifferentiation of ameloblasts. Anatomy and Embryology. 197(6). 469–475. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026